ALX40-4C [768]
ALX40-4C
| SMILES | CC(=O)NC(CCCN=C(N)N)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCNC(=N)N)C(N)=O |
| InChIKey | LGLVVVCSQBZONM-UHFFFAOYSA-N |
| Sequence | RRRRRRRRR |
| HELM | PEPTIDE1{[ac].[dR].[dR].[dR].[dR].[dR].[dR].[dR].[dR].[dR].[am]}$$$$ |
Chemical Properties
| Hydrogen bond acceptors | None |
| Hydrogen bond donors | None |
| Rotatable bonds | None |
| Log P | None |
| Molecular weight (Da) | None |
Database connections
|
|
No bioactivity data available.
ALX40-4C
Drug properties
| Molecular type | Peptide |
| Physiological/Surrogate | Surrogate |
| Approved drug | No |
Distribution across phases (no. indications)
Phase I
0
Phase II
0
Phase III
0
Phase IV
0
Database connections
|
|